{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:25:45Z","timestamp":1790717145938,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"vor","delay-in-days":265,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.rmcr.2021.101520","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T19:14:08Z","timestamp":1633115648000},"page":"101520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Mepolizumab and dupilumab as a replacement to systemic glucocorticoids for the treatment of Chronic Eosinophilic Pneumonia and Allergic Bronchopulmonary Aspergillosis - Case series, Almoosa specialist hospital"],"prefix":"10.1016","volume":"34","author":[{"given":"Safwat A.M.","family":"Eldaabossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amgad","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda'a","family":"Anshasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmcr.2021.101520_bib1","unstructured":"Salahuddin M, Anjum F, Cherian SV. StatPearls . Pulmonary Eosinophilia. Stat Pearls Publishing; Treasure Island (FL): Dec 4, 2020."},{"issue":"2","key":"10.1016\/j.rmcr.2021.101520_bib2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.chest.2020.09.247","article-title":"Approach to eosinophilia presenting with pulmonary symptoms","volume":"159","author":"Rosenberg","year":"2021","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmcr.2021.101520_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5144\/0256-4947.2012.32","article-title":"Eosinophilic pneumonia: experience at two tertiary care referral hospitals in Saudi Arabia","volume":"32","author":"Al-Jahdali","year":"2012","journal-title":"Ann. Saudi Med."},{"key":"10.1016\/j.rmcr.2021.101520_bib4","first-page":"91","article-title":"Allergic bronchopulmonary aspergillosis: a systematic review of its management with a call to action in Saudi Arabia","volume":"3","author":"AlShareef","year":"2020","journal-title":"J. Nat. Sci. Med."},{"key":"10.1016\/j.rmcr.2021.101520_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1053\/rmed.2001.1047","article-title":"Allergic bronchopulmonary mycosis in patients with asthma: period prevalence at a university hospital in Saudi Arabia","volume":"95","author":"Al-Mobeireek","year":"2001","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmcr.2021.101520_bib6","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1080\/17476348.2016.1249853","article-title":"Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis","volume":"10","author":"Agarwal","year":"2016","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.rmcr.2021.101520_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-222344","article-title":"Asthmatic adult with marked blood eosinophilia: is it truly asthma?","author":"Tan","year":"2018","journal-title":"BMJ Case Rep."},{"issue":"11","key":"10.1016\/j.rmcr.2021.101520_bib8","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/ajh.24880","article-title":"World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management","volume":"92","author":"Gotlib","year":"2017","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.rmcr.2021.101520_bib9","series-title":"Chronic eosinophilic pneumonia. UpToDate: Aug 17","author":"Brown","year":"2020"},{"issue":"3","key":"10.1016\/j.rmcr.2021.101520_bib10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.alit.2017.12.004","article-title":"Long-term management and persistent impairment of pulmonary function in chronic eosinophilic pneumonia: a review of the previous literature","volume":"67","author":"Suzuki","year":"2018","journal-title":"Allergol. Int."},{"issue":"4","key":"10.1016\/j.rmcr.2021.101520_bib11","article-title":"Treating allergic bronchopulmonary aspergillosis: a review","volume":"11","author":"Patel","year":"2019","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.rmcr.2021.101520_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1183\/13993003.01816-2015","article-title":"Treating allergic bronchopulmonary aspergillosis: the way forward","volume":"47","author":"Moss","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"10","key":"10.1016\/j.rmcr.2021.101520_bib13","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/cea.12333","article-title":"Antifungal treatment in allergic bronchopulmonary aspergillosis with and without cystic fibrosis: a systematic review","volume":"44","author":"Moreira","year":"2014","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.rmcr.2021.101520_bib14","first-page":"CD002204","article-title":"Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis","volume":"11","author":"Elphick","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.rmcr.2021.101520_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/1744666X.2017.1232620","article-title":"Allergic bronchopulmonary aspergillosis in asthma","volume":"13","author":"Knutsen","year":"2017","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.rmcr.2021.101520_bib16","series-title":"Clinical manifestations and diagnosis of allergic bronchopulmonary aspergillosis","author":"Akuthota","year":"2020"},{"key":"10.1016\/j.rmcr.2021.101520_bib17","first-page":"1","article-title":"Anti-interleukin (IL)-5 as a steroid-sparing agent in chronic eosinophilic pneumonia","author":"Sarkis","year":"2018","journal-title":"J. Asthma"},{"key":"10.1016\/j.rmcr.2021.101520_bib18","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/02770903.2018.1534966","article-title":"Favorable response to asthma-dosed subcutaneous mepolizumab in eosinophilic pneumonia","volume":"56","author":"Lin","year":"2019","journal-title":"J. Asthma"},{"key":"10.1016\/j.rmcr.2021.101520_bib19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00408-020-00336-3","article-title":"Real-life study of mepolizumab in idiopathic chronic eosinophilic pneumonia","volume":"198","author":"Brenard","year":"2020","journal-title":"Lung"},{"key":"10.1016\/j.rmcr.2021.101520_bib20","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1016\/j.jaip.2020.06.053","article-title":"Effect of mepolizumab alone in chronic eosinophilic pneumonia relapse: a case report","volume":"8","author":"Ciuffreda","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"2","key":"10.1016\/j.rmcr.2021.101520_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/rcr2.514","article-title":"Effectiveness of mepolizumab for eosinophilic pneumonia following bronchial thermoplasty","volume":"8","author":"Otoshi","year":"2020","journal-title":"Respirol. Case Rep."},{"issue":"11","key":"10.1016\/j.rmcr.2021.101520_bib22","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/02770903.2018.1534966","article-title":"Favorable response to asthma-dosed subcutaneous mepolizumab in eosinophilic pneumonia","volume":"56","author":"Lin","year":"2019","journal-title":"J. Asthma"},{"key":"10.1016\/j.rmcr.2021.101520_bib23","first-page":"A1522","article-title":"Management of chronic eosinophilic pneumonia with mepolizumab","volume":"199","author":"Lawrence","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmcr.2021.101520_bib24","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.jaip.2018.06.017","article-title":"A case of chronic eosinophilic pneumonia successfully treated with mepolizumab","volume":"6","author":"To","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"5","key":"10.1016\/j.rmcr.2021.101520_bib25","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jaip.2018.03.011","article-title":"Eosinophilic pneumonias","volume":"6","author":"Allen","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmcr.2021.101520_bib26","first-page":"2020","article-title":"Mepolizumab: an alternative therapy for idiopathic chronic eosinophilic pneumonia with glucocorticoid intolerance","volume":"9","author":"Kisling","year":"2020","journal-title":"Drugs Context (US)"},{"key":"10.1016\/j.rmcr.2021.101520_bib27","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2147\/TCRM.S207402","article-title":"A case of chronic eosinophilic pneumonia in a patient treated with dupilumab","volume":"15","author":"Menzella","year":"2019","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.rmcr.2021.101520_bib28","first-page":"A4942","article-title":"A case of dupilumab related eosinophilic pneumonia","volume":"201","author":"Devaraj","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmcr.2021.101520_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1753466620961648","article-title":"Use of monoclonal antibodies for allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis: literature review","volume":"14","author":"Eraso","year":"2020","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"1","key":"10.1016\/j.rmcr.2021.101520_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12890-018-0617-5","article-title":"A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab","volume":"18","author":"Terashima","year":"2018","journal-title":"BMC Pulm. Med."},{"issue":"26","key":"10.1016\/j.rmcr.2021.101520_bib31","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmcr.2021.101520_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2147\/TCRM.S157882","article-title":"Chronic eosinophilic pneumonia: clinical perspectives","volume":"15","author":"Crowe","year":"2019","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.rmcr.2021.101520_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2017.12.741","article-title":"Combination anti-IgE and anti-IL5 therapies in patients with severe persistent asthma and allergic bronchopulmonary aspergillosis (ABPA)","author":"Patel","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmcr.2021.101520_bib34","doi-asserted-by":"crossref","unstructured":"Tolebeyan A, Mohammadi O, Vaezi Z, et al. (August 12, 2020) mepolizumab as possible treatment for allergic bronchopulmonary aspergillosis: a review of eight cases. Cureus 12(8): e9684. DOI 10.7759\/cureus.9684.","DOI":"10.7759\/cureus.9684"},{"key":"10.1016\/j.rmcr.2021.101520_bib35","first-page":"59","article-title":"Allergic bronchopulmonary aspergillosis successfully treated with mepolizumab: case report and review of the literature","volume":"26","author":"Hirota","year":"2019","journal-title":"Respir. Med. Case Rep."},{"issue":"4","key":"10.1016\/j.rmcr.2021.101520_bib36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.alit.2018.03.004","article-title":"Severe asthma concomitant with allergic bronchopulmonary aspergillosis successfully treated with mepolizumab","volume":"67","author":"Oda","year":"2018","journal-title":"Allergol. Int."},{"issue":"4","key":"10.1016\/j.rmcr.2021.101520_bib37","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jaip.2017.01.013","article-title":"Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis","volume":"5","author":"Altman","year":"2017","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"2","key":"10.1016\/j.rmcr.2021.101520_bib38","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jaip.2019.11.031","article-title":"Dupilumab treatment for allergic bronchopulmonary aspergillosis: a case series","volume":"8","author":"Ramonell","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmcr.2021.101520_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13223-020-00454-w","article-title":"Differential response to biologics in a patient with severe asthma and ABPA: a role for dupilumab?","volume":"16","author":"M\u00fcmmler","year":"2020","journal-title":"Allergy Asthma Clin. Immunol."},{"issue":"2","key":"10.1016\/j.rmcr.2021.101520_bib40","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jaip.2019.08.050","article-title":"Dupilumab efficacy in patients with uncontrolled, moderate-to-severe allergic asthma","volume":"8","author":"Corren","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"4","key":"10.1016\/j.rmcr.2021.101520_bib41","first-page":"2021","article-title":"Dupilumab: a new contestant to corticosteroid in allergic bronchopulmonary aspergillosis","author":"Ali","year":"2021","journal-title":"Oxf. Med. Case Rep."},{"key":"10.1016\/j.rmcr.2021.101520_bib42","doi-asserted-by":"crossref","DOI":"10.2169\/internalmedicine.6679-20","article-title":"Successful treatment of mepolizumab- and prednisolone-resistant allergic bronchopulmonary aspergillosis with dupilumab","author":"Mikura","year":"2021","journal-title":"Intern. Med."}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007121001829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007121001829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:06:36Z","timestamp":1761959196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007121001829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":42,"alternative-id":["S2213007121001829"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2021.101520","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mepolizumab and dupilumab as a replacement to systemic glucocorticoids for the treatment of Chronic Eosinophilic Pneumonia and Allergic Bronchopulmonary Aspergillosis - Case series, Almoosa specialist hospital","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2021.101520","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101520"}}